AAAAAA

   
Results: 1-19 |
Results: 19
Spontaneous and MNNG-induced reversion of an EGFP construct in HeLa cells:An assay for observing mutations in living cells by fluorescent microscopy
Authors: Gemignani, F Landi, S DeMarini, DM Kole, R
Citation: F. Gemignani et al., Spontaneous and MNNG-induced reversion of an EGFP construct in HeLa cells:An assay for observing mutations in living cells by fluorescent microscopy, HUM MUTAT, 18(6), 2001, pp. 526-534
Nuclear antisense effects of neutral, anionic and cationic oligonucleotideanalogs
Authors: Sazani, P Kang, SH Maier, MA Wei, CF Dillman, J Summerton, J Manoharan, M Kole, R
Citation: P. Sazani et al., Nuclear antisense effects of neutral, anionic and cationic oligonucleotideanalogs, NUCL ACID R, 29(19), 2001, pp. 3965-3974
Strong RNA splicing enhancers identified by a modified method of cycled selection interact with SR protein
Authors: Tian, HH Kole, R
Citation: Hh. Tian et R. Kole, Strong RNA splicing enhancers identified by a modified method of cycled selection interact with SR protein, J BIOL CHEM, 276(36), 2001, pp. 33833-33839
Modification of alternative splicing of Bcl-x Pre-mRNA in prostate and breast cancer cells - Analysis of apoptosis and cell death
Authors: Mercatante, DR Bortner, CD Cidlowski, JA Kole, R
Citation: Dr. Mercatante et al., Modification of alternative splicing of Bcl-x Pre-mRNA in prostate and breast cancer cells - Analysis of apoptosis and cell death, J BIOL CHEM, 276(19), 2001, pp. 16411-16417
Pre-mRNA splicing as a target for antisense oligonucleotides
Authors: Kole, R Mercatante, D
Citation: R. Kole et D. Mercatante, Pre-mRNA splicing as a target for antisense oligonucleotides, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, 2001, pp. 517-539
Modification of alternative splicing pathways as a potential approach to chemotherapy
Authors: Mercatante, D Kole, R
Citation: D. Mercatante et R. Kole, Modification of alternative splicing pathways as a potential approach to chemotherapy, PHARM THERA, 85(3), 2000, pp. 237-243
Antisense oligonucleotides and RNAs as modulators of pre-mRNA splicing
Authors: Sierakowska, H Gorman, L Kang, SH Kole, R
Citation: H. Sierakowska et al., Antisense oligonucleotides and RNAs as modulators of pre-mRNA splicing, METH ENZYM, 313, 2000, pp. 506-521
Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients
Authors: Lacerra, G Sierakowska, H Carestia, C Fucharoen, S Summerton, J Weller, D Kole, R
Citation: G. Lacerra et al., Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients, P NAS US, 97(17), 2000, pp. 9591-9596
Restoration of correct splicing of thalassemic beta-globin pre-mRNA by modified U1 snRNAs
Authors: Gorman, L Mercatante, DR Kole, R
Citation: L. Gorman et al., Restoration of correct splicing of thalassemic beta-globin pre-mRNA by modified U1 snRNAs, J BIOL CHEM, 275(46), 2000, pp. 35914-35919
Antisense oligonucleotides as modulators of pre-mRNA splicing
Authors: Sierakowska, H Agrawal, S Kole, R
Citation: H. Sierakowska et al., Antisense oligonucleotides as modulators of pre-mRNA splicing, METH MOL B, 133, 2000, pp. 223-233
Sensitivity of splice sites to antisense oligonucleotides in vivo
Authors: Sierakowska, H Sambade, MJ Schumperli, D Kole, R
Citation: H. Sierakowska et al., Sensitivity of splice sites to antisense oligonucleotides in vivo, RNA, 5(3), 1999, pp. 369-377
Delivery of antisense oligonucleotides and plasmid DNA with various carrier agents
Authors: Kang, SH Zirbes, EL Kole, R
Citation: Sh. Kang et al., Delivery of antisense oligonucleotides and plasmid DNA with various carrier agents, ANTISENSE N, 9(6), 1999, pp. 497-505
A new routine in molecular gymnastics
Authors: Kole, R
Citation: R. Kole, A new routine in molecular gymnastics, NAT BIOTECH, 17(3), 1999, pp. 223-224
Double-target antisense U7 snRNAs promote efficient skipping of an aberrant exon in three human beta-thalassemic mutations
Authors: Suter, D Tomasini, R Reber, U Gorman, L Kole, R Schumperli, D
Citation: D. Suter et al., Double-target antisense U7 snRNAs promote efficient skipping of an aberrant exon in three human beta-thalassemic mutations, HUM MOL GEN, 8(13), 1999, pp. 2415-2423
Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides
Authors: Wilton, SD Lloyd, F Carville, K Fletcher, S Honeyman, K Agrawal, S Kole, R
Citation: Sd. Wilton et al., Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides, NEUROMUSC D, 9(5), 1999, pp. 330-338
Antisense pharmacodynamics: Critical issues in the transport and delivery of antisense oligonucleotides
Authors: Juliano, RL Alahari, S Yoo, H Kole, R Cho, M
Citation: Rl. Juliano et al., Antisense pharmacodynamics: Critical issues in the transport and delivery of antisense oligonucleotides, PHARM RES, 16(4), 1999, pp. 494-502
Novel cationic amphiphiles as delivery agents for antisense oligonucleotides
Authors: DeLong, RK Yoo, H Alahari, SK Fisher, M Short, SM Kang, SH Kole, R Janout, V Regan, SL Juliano, RL
Citation: Rk. Delong et al., Novel cationic amphiphiles as delivery agents for antisense oligonucleotides, NUCL ACID R, 27(16), 1999, pp. 3334-3341
Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides
Authors: Friedman, KJ Kole, J Cohn, JA Knowles, MR Silverman, LM Kole, R
Citation: Kj. Friedman et al., Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides, J BIOL CHEM, 274(51), 1999, pp. 36193-36199
Antisense oligonucleotides with different backbones - Modification of splicing pathways and efficacy of uptake
Authors: Schmajuk, G Sierakowska, H Kole, R
Citation: G. Schmajuk et al., Antisense oligonucleotides with different backbones - Modification of splicing pathways and efficacy of uptake, J BIOL CHEM, 274(31), 1999, pp. 21783-21789
Risultati: 1-19 |